In this Issue:
Making targeted therapy possible for ovarian cancer
Biomarkers
Germline and host factors influencing drug response and toxicity
Asia Pacific perspectives
Trainees’ proffered papers
Best of the best research in 2013
Please login below to download this issue (PDF)